Peer-reviewed veterinary case report
Cataract surgery results in Miniature Schnauzers after 1 year
By Rogen, Andrew J & Moradi Rekabdarkolaee, Hossein·Published in Veterinary ophthalmology·2020·Eye Care for Animals, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Retrospective review of cataract surgery outcomes in Miniature Schnauzers.
Plain-English summary
A group of Miniature Schnauzers with cataracts underwent surgery, and 93.5% of their eyes were able to see well one year later. Many of these dogs also had other health issues like diabetes and high cholesterol at the time of surgery. After the procedure, some dogs were given a medication called dorzolamide, which helped manage their cholesterol levels. The study suggests that adjusting their diet and adding omega-3 fatty acids could help reduce certain complications after surgery. Overall, the cataract surgery was successful despite the dogs having other metabolic diseases.
People also search for: Miniature Schnauzer cataract surgery success · dog cataract treatment options · diabetic dog eye problems
Abstract
OBJECTIVE: Miniature Schnauzers commonly develop both inherited and diabetic cataracts. Miniature Schnauzers also often present with concurrent metabolic disease at the time of cataract surgery. The purpose of this study was to evaluate cataract surgery outcomes in Miniature Schnauzers. MATERIALS AND METHODS: The Eye Care for Animals electronic medical record database (2012-2018) was searched for "phacoemulsification" and "Miniature Schnauzer." A minimum follow-up time of 1 year was required for inclusion in the study. Clinical history, pre- and postoperative bloodwork, postoperative treatments, and visual outcomes were reviewed in all cases. RESULTS: Cataract surgery was performed on 67 patients and 124 eyes. 93.5% (116/124) of operated eyes were visual 1 year following cataract surgery. At the time of surgery, 79.1% were diabetic, 64.2% had hypercholesterolemia, 55.2% had hypertriglyceridemia, 16.4% had hyperadrenocorticism, and 9% had a history of pancreatitis. Dorzolamide was used postoperatively in 61.2% of patients, and its use was significantly associated with postoperative cholesterol levels above reference range. Lipemic aqueous occurred in 13.4% of patients. CONCLUSIONS: Miniature Schnauzers presenting for cataract surgery are frequently affected by metabolic diseases and dyslipidemia; however, cataract surgery outcomes were not significantly affected during the study period. Dietary management, omega-3 fatty acid supplementation, and oral fibrates may reduce the incidence of lipemic aqueous in Miniature Schnauzers.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/32159283/